Skip to main content
. 2022 Jun 22;22:688. doi: 10.1186/s12885-022-09751-6

Table 2.

Characteristics of matched pairs

Myosteatosis n = 98 No Myosteatosis n = 98 LMM n = 102 Normal MM n = 102
N % N % p N % N % p
Age 0.88 1
 < 61 62 63.3 64 65.3 68 66.7 69 67.6
 >  = 61 36 36.7 34 34.7 34 33.3 33 32.4
Sex 0.60 0.85
Female 22 22.4 18 18.4 18 17.6 16 15.7
Male 76 77.6 80 81.6 84 82.4 86 84.3
Race 0.65 0.81
White 86 87.8 89 90.8 94 92.2 92 90.2
BIPOC 12 12.2 9 9.2 8 7.8 10 9.8
Comorbidities 0.96 0.86
None 16 16.3 18 18.4 17 16.7 19 18.6
1 25 25.5 27 27.6 25 24.5 27 26.5
2 16 16.3 14 14.3 14 13.7 16 15.7
3 +  41 41.8 39 39.8 46 45.1 40 39.2
Tumor site 0.79 0.66
Oropharynx 44 44.9 46 46.9 48 47.1 53 52.0
Larynx 31 31.6 33 33.7 32 31.4 26 25.5
Other 23 23.5 19 19.4 22 21.6 23 22.5
AJCC stage 0.34 0.98
0-II 28 28.6 32 32.7 30 29.4 32 31.4
III 19 19.4 25 25.5 24 23.5 24 23.5
IV 51 52.0 41 41.8 48 47.1 46 45.1
HPV 0.81 0.68
Positive 21 21.4 23 23.5 22 21.6 26 25.5
Negative 29 29.6 32 32.7 35 34.3 37 36.3
N/A 48 49.0 43 43.9 45 44.1 39 38.2
Treatment 1 1
RT only 7 7.1 8 8.2 6 5.9 6 5.9
Chemoradiation 91 92.9 90 91.8 96 94.1 96 94.1
Smoking 0.98 0.80
Current 20 20.4 20 20.4 22 21.6 26 25.5
Former 45 45.9 47 48.0 50 49.0 48 47.1
Never 33 33.7 31 31.6 30 29.4 28 27.5
Alcohol 0.92 0.75
Current 18 18.4 18 18.4 19 18.6 16 15.7
Former 20 20.4 21 21.4 20 19.6 26 25.5
Never 56 57.1 57 58.2 60 58.8 58 56.9
N/A 4 4.1 2 2.0 3 2.9 2 2.0
Muscle mass 1 NA
Normal 49 50.0 48 49.0 0 0.0 102 100.0
Low 49 50.0 50 51.0 102 100.0 0 0.0
Myosteatosis NA 1
No 0 0.0 98 100.0 53 52.0 53 52.0
Yes 98 100.0 0 0.0 49 48.0 49 48.0

Abbreviations: AJCC American Joint Committee on Cancer, BIPOC Black Indigenous People of Color, LMM Low muscle mass, MM Muscle mass, RT Radiation therapy

Data are presented as frequency (percent), mean (SD)